Molecule
Brands
Company
Product Search
by Molecule
by Brands
by Company
NCE
Modified, Unique products
Recent KFDA Approval &
NHI enlisting
API Business info
Customer survey
Based on Production Vol.
DMF-Molecule, Status & Process
(Market & customer)
DMF Filling Status
Patent Status
My API profile Registration
Member's Lounge
General Market Information
KFDA registration process
DMF Filing
National Health Formulary enlisting
Law or Regulation
Major Pharmaceutical company
API importers directory
Distribution & Wholesaler
CRO & Other service Provider
Co-Biz Avenue
PharmaToday
Pharmaceutical Korea
Q & A
FAQ
General Q&A
Market Q&A
Business Inquiry
to Pharmalink
My Page
Company Registration
Company ID Management
Company Profile
Product description
>
API description
My Profile
Contacts in / out
General Q&A
Detail Information
Product Search
Detail Information
Clonixin soft cap.
Company
Jeil Health Science
ETC/OTC
OTC
MOHSA Class
ATC
M01AX
NHI Price
Reg/Mark
Not sale
Unit
Pill ID
(Front) (Back)
Composition
clonixin lysinate 125mg
Indication
Dosage
다음의 경증 또는 중등도 통증의 완화 : 근육통, 신경통, 외상 후 및 수술 후 통증, 두통, 치통, 귀통증
성인 : 클로닉신리시네이트로서 1회 125∼250 mg을 1일 3회 경구투여한다.
Clonixin soft cap.
[Close]
PharmaLink.kr
| Jin BD 2nd floor, Sadangdong 1039-59, Dongjak-Gu, Seoul
E-Mail :
pharmabase@nate.com
Tel : 82-70-7815-2200
Copyright ⓒ2013~2016 PharmaLink.Kr ALL RIGHTS RESERVED.